|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 1997; 30:1606-1610 © 1997 by the American College of Cardiology Foundation |
Department of Medicine, Duke University Medical Center, Durham, North Carolina, USA. mahaf002@mc.duke.edu
OBJECTIVES: This study sought to evaluate the incidence of ocular hemorrhage in patients with and without diabetes after thrombolytic therapy for acute myocardial infarction. BACKGROUND: Ocular hemorrhage after thrombolysis has been reported rarely. However, there is concern that the risk is increased in patients with diabetes. In fact, diabetic hemorrhagic retinopathy has been identified as a contraindication to thrombolytic therapy without clear evidence that these patients have an increased risk for ocular hemorrhage. METHODS: We identified all suspected ocular hemorrhages from bleeding complications reported in patients enrolled in the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I trial. Additional information was collected on a one-page data form. We compared the incidence and location of ocular hemorrhages in patients with and without diabetes. RESULTS: There were 40,899 patients (99.7%) with information about diabetic history and ocular bleeding. Twelve patients (0.03%) had an ocular hemorrhage. Intraocular hemorrhage was confirmed in only one patient. There were 6,011 patients (15%) with diabetes, of whom only 1 had an ocular hemorrhage (eyelid hematoma after a documented fall). The upper 95% confidence intervals for the incidence of intraocular hemorrhage in patients with and without diabetes were 0.05% and 0.006%, respectively. CONCLUSIONS: Ocular hemorrhage and, more important, intraocular hemorrhage after thrombolytic therapy for acute myocardial infarction is extremely uncommon. The calculated upper 95% confidence interval for the incidence of intraocular hemorrhage in patients with diabetes was only 0.05%. We conclude that diabetic retinopathy should not be considered a contraindication to thrombolysis in patients with an acute myocardial infarction.
This article has been cited by other articles:
|
|
 |
|
  T. S. Cunneen and N. Morlet Retro-Orbital Hemorrhage after Thrombolysis for Acute Myocardial Infarction N. Engl. J. Med., October 4, 2007; 357(14): 1448 - 1449. [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. Hurst and R. W. Lee Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management Ann Intern Med, November 18, 2003; 139(10): 824 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W Savage and K. S Channer Improving the management of acute myocardial infarction BMJ, November 23, 2002; 325(7374): 1185 - 1186. [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. BOORD, A. L. GRABER, J. W. CHRISTMAN, and A. C. POWERS Practical Management of Diabetes in Critically Ill Patients Am. J. Respir. Crit. Care Med., November 15, 2001; 164(10): 1763 - 1767. [Full Text] [PDF]
|
|
|
|
 |
|
 C.-K Wong and H.D White Dithering over the treatment of diabetics with acute myocardial infarction Eur. Heart J., December 1, 2000; 21(23): 1907 - 1909. [PDF]
|
|
|
|
|
|
I Gustafsson, P Hildebrandt, M Seibaek, T Melchior, C Torp-Pedersen, L Kober, and P Kaiser-Nielsen Long-term prognosis of diabetic patients with myocardial infarction: relation to antidiabetic treatment regimen Eur. Heart J., December 1, 2000; 21(23): 1937 - 1943. [Abstract] [PDF]
|
|
|
|
|
|
D.K McGuire, H Emanuelsson, C.B Granger, E Magnus Ohman, D.J Moliterno, H.D White, D Ardissino, J.W Box, R.M Califf, and E.J Topol Influence of diabetes mellitus on clinical outcomes across the spectrum of acute coronary syndromes. Findings from the GUSTO-IIb Study Eur. Heart J., November 1, 2000; 21(21): 1750 - 1758. [Abstract] [PDF]
|
|
|
|
 |
|
 D. M. Shindler, S. T. Palmeri, T. A. Antonelli, L. A. Sleeper, J. Boland, T. P. Cocke, J. S. Hochman, and for the SHOCK Investigators Diabetes mellitus in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry J. Am. Coll. Cardiol., September 1, 2000; 36(3_Suppl_A): 1097 - 1103. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Mehta, T. J. Ruane, P. A. McCargar, K. A. Eagle, and E. J. Stalhandske The Treatment of Elderly Diabetic Patients With Acute Myocardial Infarction: Insight From Michigan's Cooperative Cardiovascular Project Arch Intern Med, May 8, 2000; 160(9): 1301 - 1306. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Mak and E. J. Topol Emerging concepts in the management of acute myocardial infarction in patients with diabetes mellitus J. Am. Coll. Cardiol., March 1, 2000; 35(3): 563 - 568. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. White and F. J. J. Van de Werf Thrombolysis for Acute Myocardial Infarction Circulation, April 28, 1998; 97(16): 1632 - 1646. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Diabetic Retinopathy Should Not Preclude Thrombolysis Journal Watch Emergency Medicine, February 1, 1998; 1998(201): 6 - 6. [Full Text]
|
|
|
|
 |
|
 THROMBOLYSIS NOT CONTRAINDICATED WITH DIABETIC RETINOPATHY Journal Watch (General), December 9, 1997; 1997(1209): 1 - 1. [Full Text]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
